PL358082A1 - Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt - Google Patents

Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt

Info

Publication number
PL358082A1
PL358082A1 PL35808202A PL35808202A PL358082A1 PL 358082 A1 PL358082 A1 PL 358082A1 PL 35808202 A PL35808202 A PL 35808202A PL 35808202 A PL35808202 A PL 35808202A PL 358082 A1 PL358082 A1 PL 358082A1
Authority
PL
Poland
Prior art keywords
inclusion bodies
antigenes
immunization
nutritional
animals
Prior art date
Application number
PL35808202A
Other languages
English (en)
Other versions
PL199190B1 (pl
Inventor
Andrzej Płucienniczak
Małgorzata Kęsik
Anna Porębska
Violetta Sączyńska
Bogusław Szewczyk
Jolanta Ficińska
Original Assignee
Instytut Biotechnologii i Antybiotyków
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii i Antybiotyków, Uniwersytet Gdański filed Critical Instytut Biotechnologii i Antybiotyków
Priority to PL358082A priority Critical patent/PL199190B1/pl
Priority to AU2003294192A priority patent/AU2003294192A1/en
Priority to DE60327896T priority patent/DE60327896D1/de
Priority to PCT/PL2003/000152 priority patent/WO2004058806A2/en
Priority to AT03789658T priority patent/ATE432943T1/de
Priority to EP20030789658 priority patent/EP1603938B1/en
Priority to ES03789658T priority patent/ES2328350T3/es
Publication of PL358082A1 publication Critical patent/PL358082A1/pl
Publication of PL199190B1 publication Critical patent/PL199190B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL358082A 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt PL199190B1 (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL358082A PL199190B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt
AU2003294192A AU2003294192A1 (en) 2002-12-31 2003-12-31 Inclusion bodies as antigens for the oral vaccination of animals against csfv
DE60327896T DE60327896D1 (de) 2002-12-31 2003-12-31 Einschlusskörper als antigene für die orale impfung von tieren gegen csfv
PCT/PL2003/000152 WO2004058806A2 (en) 2002-12-31 2003-12-31 Inclusion bodies as antigens for the oral vaccination of animals against csfv
AT03789658T ATE432943T1 (de) 2002-12-31 2003-12-31 Einschlusskörper als antigene für die orale impfung von tieren gegen csfv
EP20030789658 EP1603938B1 (en) 2002-12-31 2003-12-31 Inclusion bodies as antigens for the oral vaccination of animals against csfv
ES03789658T ES2328350T3 (es) 2002-12-31 2003-12-31 Cuerpos de inclusion como antigenos para la vacunacion oral de animales frente a vppc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL358082A PL199190B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt

Publications (2)

Publication Number Publication Date
PL358082A1 true PL358082A1 (pl) 2004-07-12
PL199190B1 PL199190B1 (pl) 2008-08-29

Family

ID=32678128

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358082A PL199190B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt

Country Status (7)

Country Link
EP (1) EP1603938B1 (pl)
AT (1) ATE432943T1 (pl)
AU (1) AU2003294192A1 (pl)
DE (1) DE60327896D1 (pl)
ES (1) ES2328350T3 (pl)
PL (1) PL199190B1 (pl)
WO (1) WO2004058806A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116655751A (zh) * 2016-08-01 2023-08-29 浙江海隆生物科技有限公司 重组猪瘟e2蛋白及其亚单位疫苗的制备方法和应用
CN107619435B (zh) * 2017-09-19 2021-03-16 中国农业科学院上海兽医研究所 一种猪瘟病毒e2蛋白的抗原表位、抗体的制备及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA901719B (en) * 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics
WO2003013598A2 (en) * 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases

Also Published As

Publication number Publication date
AU2003294192A8 (en) 2004-07-22
EP1603938B1 (en) 2009-06-03
PL199190B1 (pl) 2008-08-29
EP1603938A2 (en) 2005-12-14
WO2004058806A2 (en) 2004-07-15
ATE432943T1 (de) 2009-06-15
WO2004058806A3 (en) 2004-10-28
ES2328350T3 (es) 2009-11-12
DE60327896D1 (de) 2009-07-16
AU2003294192A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
EP1594536A4 (en) ADJUVANT INFLUENZA VACCINE
ITMI20021897A1 (it) Seggiolone con dondolo per bambini.
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
SG163598A1 (en) Lawsonia vaccine and methods of use thereof
NO20052149D0 (no) Vaksine.
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
PL380950A1 (pl) Pewne związki amionoalkiloglukozaminidofosforanowe i ich zastosowanie
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
CR8240A (es) Hidrolizado de colageno
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
PL358081A1 (pl) Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
AP2003002867A0 (en) Immune response potentiation
MXPA05013703A (es) Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
PT1474415E (pt) Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas
IL193391A0 (en) Influenza antigens, vaccine compositions, and related methods
RU2003136675A (ru) Способ повышения сохранности молодняка крупного рогатого скота
ZA200202511B (en) A process for the preparation of a vaccine for the treatment of tuberculosis and other intracellular infections diseases and the vaccine produced by the process.
ES1051959Y (es) Dispositivo para generar efectos en muñecos.
DE10327334B4 (de) Still- und Lagerungskissen
TH22810S1 (th) อุปกรณ์นวด